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A B S T R A C T
Ceramides (CER) are essential sphingolipids of the stratum corneum (SC) that play an important role in
maintaining cutaneous barrier function. Skin barrier defects occur in both human beings and dogs af-
fected with atopic dermatitis, and have been associated with decreased CER concentrations and
morphological alterations in the SC. The aim of the present study was to investigate the changes induced
by three different sphingolipid extracts (SPE-1, SPE-2 and SPE-3) on the morphological structure and lipid
composition of canine skin, using an in vitro model, whereby keratinocytes were seeded onto ﬁbroblast-
embedded collagen type I matrix at the air–liquid interface. Cell cultures were supplemented with SPE-
1, SPE-2, SPE-3 or vehicle (control) for 14 days. The relative concentrations of lipids were determined
by ultra-performance liquid chromatography coupled to mass spectrometry. The ultrastructural mor-
phology of samples was examined by transmission electronmicroscopy. SPE-1 induced signiﬁcant elevation
in total CERs, CER[NS], CER[NDS], CER[NP], CER[AS], CER[AP], CER[EOS] and CER[EOP] subclasses, whereas
SPE-2 induced a signiﬁcant elevation in total CER, CER[AP] and CER[EOS] compared with control condi-
tions. Ultrastructural analysis revealed an increase in lamellar-lipid structures in the SC of SPE-1-
treated samples. The ﬁndings demonstrated that SPE-1 stimulates production of CERs, as shown by changes
in lipid composition and ultrastructural morphology. Thus, SPE-1 contributes to the formation of a well-
organised SC and represents a potential therapeutic target for improving skin barrier function in atopic
dermatitis.
© 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Introduction
The stratum corneum (SC) of the skin, the outermost layer of the
epidermis, plays an important role in barrier function, by limiting
the penetration of substances and pathogens, and restricting water
movement into and out of the skin. The corniﬁed cell envelope is
located in the inner cytoplasmic membrane of corneocytes and is
composed of a cross-linked protein layer, which provides structur-
al and mechanical integrity to the cells (Nemes and Steinert, 1999;
Candi et al., 2005) and confers a scaffold structure to the extracel-
lular lamellar lipids (Bouwstra and Ponec, 2006). Assembly of the
extracellular lamellar lipids is a crucial factor in maintaining per-
meability barrier function (Swartzendruber et al., 1987, 1989).
Precursors of the extracellular lipid matrix, including phospholip-
ids, glucosylceramides, sphingomyelin and cholesterol, are located
in the lamellar granules of keratinocytes at the upper stratum
spinosum and stratum granulosum, and originate from the Golgi
apparatus (Downing et al., 1987; Candi et al., 2005; Feingold, 2007,
2011).
In human beings, the lipid matrix consists mainly of three lipid
classes: ceramides (CER), fatty acids and cholesterol (Elias and
Feingold, 1992). Ceramides, as the major constituent of extracel-
lular lamellar lipids, play a key role in determining cutaneous barrier
function and the water-holding capacity of the SC (Bouwstra and
Ponec, 2006; Jungersted et al., 2008). Canine SC has a CER proﬁle
closely resembling that of human beings (Popa et al., 2010). These
extremely complex skin CERs include numerous molecular sub-
classes consisting of a combination of sphingoid moieties, including
sphingosine [S], dihydrosphingosine [DS], phytosphingosine [P] and
6-hydroxy-sphingosine [H], linked via an amide bond to a fatty acid
moiety, which may be non-hydroxy [N], α-hydroxy [A], or ester-
linked ω-hydroxy [EO]. At present, the following CER subclasses have
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been reported: CER[AH], CER[ADS], CER[AP], CER[AS], CER[EOH],
CER[EOP], CER[EOS], CER[NH], CER[NDS], CER[NP] and CER[NS]
(Masukawa et al., 2008; van Smeden et al., 2011; t’Kindt et al., 2012).
CER deﬁciency of the SC appears to be responsible, at least in
part, for the cutaneous skin barrier defect and is recognised in both
human and canine atopic dermatitis (AD) (Reiter et al., 2009;
Shimada et al., 2009; Yoon et al., 2011; Nishifuji and Yoon, 2013).
The dog has been shown to be a suitable model of human AD,
because the development of clinical and immunological altera-
tions in the disease resembles those in human beings (Santoro et al.,
2013). Canine AD is deﬁned as a genetically predisposed inﬂam-
matory and pruritic skin disease associated with immunoglobulin
E antibodies against environmental and/or food allergens
(Pucheu-Haston et al., 2015).
In canine AD, impaired cutaneous barrier function is associ-
ated with an increase in transepidermal water loss (TEWL) and,
consequently, a reduction in skin hydration (Marsella and Samuelson,
2009; Hightower et al., 2010; Marsella et al., 2011). Increased TEWL
has been associated with decreased CER levels and, in humans af-
fected with AD, CER deﬁciency can be either a primary defect, the
consequence of skin inﬂammation or both (Shimada et al., 2009;
Santoro et al., 2015). Abnormalities of SCmorphology have also been
reported in skin from AD-affected dogs, as demonstrated by
corneocyte disorganisation with wider intercellular spaces along-
side an abnormal or incomplete lipid lamellae structure (Inman et al.,
2001; Piekutowska et al., 2008; Marsella et al., 2010). There is in-
creasing evidence that such defects might lead to excessive
penetration by allergens and/or microorganisms, triggering an in-
ﬂammatory process that can become chronic (Inman et al., 2001;
Piekutowska et al., 2008; Ishida-Yamamoto et al., 2011). Recent
studies have shown improvements in skin barrier function in dogs
affected with canine AD following topical application and oral feed
supplementation of preparations containing CERs, free fatty acids
and cholesterol (Piekutowska et al., 2008; Popa et al., 2011, 2012;
Jung et al., 2013).
In vitro models, known as skin equivalents (SEs), have been de-
veloped as an alternative to use of experimental animals. These
bioengineered tissue substitutes consist of a dermal compart-
ment, mainly consisting of collagen, which acts as a scaffold for
primary cells of the epidermis (keratinocytes) and dermis (ﬁbro-
blasts), thus replicating the cellular and structural properties of skin.
SEs have been widely used in human skin biology research (Boyce
and Williams, 1993; MacNeil, 2007), cutaneous irritation studies,
toxicity testing (Welss et al., 2004; Park et al., 2010) and experi-
mental modelling to test permeability and cutaneous absorption of
different agents and formulations (Batheja et al., 2009; Tokudome
et al., 2010). Although less well characterised, canine SEmodels have
been developed (Barnhart et al., 2005; Magnol et al., 2005; Serra
et al., 2007) and a canine SE model was validated for assessing the
effects of topical oil formulations on skin morphology, functional-
ity and changes in lipid composition (Cerrato et al., 2013). The aim
of the present study was to investigate epidermal and dermal mor-
phological structure and lipid proﬁle composition in canine SEs
exposed a number of lipid extracts rich in sphingolipids.
Materials and methods
Sphingolipid extracts
Three treatments were evaluated: sphingolipid extracts (SPE) 1–3 (Bioiberica SA).
Each extract demonstrated a different lipid proﬁle, but all were of animal origin. Com-
pounds were emulsiﬁed in phosphate buffered saline (PBS) without Ca2+ or Mg2+
to 0.1% (W/V) and serially diluted to the desired concentration.
Isolation and culture of canine skin cells
Dermal ﬁbroblasts and keratinocytes were isolated from biopsies obtained from
the abdominal skin of healthy dogs after routine surgeries unrelated to the present
study. Biopsies were collected in the Veterinary Hospital of the Universitat Autònoma
de Barcelona (UAB), after obtaining informed written consent from the owner. All
experimental protocols were supervised and approved by the Animal Ethics Com-
mittee of the UAB.
Skin samples were cleaned, cut into small fragments and enzymatically dis-
persed as previously described (Llames et al., 2006; Cerrato et al., 2013). Skin
fragments were incubated with 2 mg/mL collagenase type I solution (Sigma-
Aldrich) in Dulbecco’s Minimal Essential Medium (DMEM, Invitrogen) for 4–6 h at
37 °C until the dermis was totally digested. The cell-rich supernatant was centri-
fuged at 300 g for 5 min, washed with PBS and the resulting ﬁbroblasts were
incubated in a humidiﬁed atmosphere at 37 °C with 5% CO2 in culture medium
consisting of DMEM supplemented with 10% foetal bovine serum (FBS) and
antibiotics (Invitrogen).
The remaining epidermal fragments were subsequently washed and digested
with a solution of 0.05% trypsin and 0.02% ethylene diamine tetraacetic acid (EDTA;
Invitrogen) for 30 min at 37 °C to obtain keratinocytes. These were ﬁltered twice
with cell strainers (100 μm and 40 μm pore size, respectively; BD Biosciences) and
centrifuged at 300 g for 5 min to recover the cells. Keratinocytes were seeded onto
collagen-coated ﬂasks and cultured in a humidiﬁed atmosphere at 37 °C with 5%
CO2 in DMEM/F12 (3:1) (Invitrogen) supplemented with 10% FBS, 0.01 g/mL epi-
dermal growth factor (Austral Biologicals), 5 g/mL insulin, 7 ng/mL cholera toxin, 0.4 g/
mL hydrocortisone, 1.3 ng/mL triiodothyronine, 24 g/mL adenine (Sigma-Aldrich) and
antibiotics. Culture medium was changed every 2–3 days and cells were used for
the SE model between the second and ﬁfth passages.
Skin equivalent model
To obtain a three-dimensional SE, a collagen gel biomatrix was developed in a
transwell chamber (Corning) by adding 4 × 104/mL mature ﬁbroblasts to a 1.5 mg/
mL type I collagen solution (Sigma-Aldrich) (Cerrato et al., 2013). The collagen gel
biomatrix was cultured for 5–7 days, when 5 × 105 keratinocytes were seeded onto
it. After 24 h, SEs were lifted to the air–liquid interface and the medium was modi-
ﬁed by including 1% FBS, 0.1% L-serine, free fatty acids (15 μM linoleic acid, 7 μM
arachidonic acid and 25 μM palmitic acid), 50 μg/mL ascorbic acid, 1 μM DL-α-
tocopherol-acetate and 2.4 × 10−5 M bovine serum albumin (Sigma-Aldrich). SEs were
cultured for 48 h before replacing the medium with medium lacking FBS but with
additional 30 μM linoleic acid.
On the third day after seeding the keratinocytes, SEs were cultured in medium
supplemented with SPE-1, SPE-2, SPE-3 or vehicle only. The ﬁnal concentration of
compounds in the culture medium was 0.001% (W/V). Skin equivalents were cul-
tured over a total period of 14 days and medium and treatments were changed three
times per week.
Histological and ultrastructural studies
SEs were ﬁxed in 10% neutral buffered formalin, dehydrated in a graded series
of ethanol and embedded in paraﬃnwax. Sections (4 μm) were stained using routine
methodswith haematoxylin and eosin (H&E) for histopathology. Ultrastructural studies
were carried out by performing two different staining procedures. Firstly, samples
were treated with paraformaldehyde–glutaraldehyde, then exposed to 1% (W/V)
osmium tetroxide (TAAB) containing 0.8% (W/V) potassium hexacyanoferrate (III)
(Sigma-Aldrich) for 2 h. Samples were dehydrated through a graded acetone series,
embedded in Eponate 12 resin (Ted Pella) and polymerised for 48 h at 60 °C. Addi-
tionally, samples were treated with 2.5% glutaraldehyde, buffered in 0.1 M sodium
cacodylate, then exposed to 0.2% ruthenium tetroxide in 0.1 M cacodylate (Sigma-
Aldrich) for 1 h. After dehydration through a graded ethanol series up to 100% (W/
V), samples were embedded in Spurr resin (Ted Pella) and polymerised for 48 h at
60 °C. Ultrathin sections (70 nm) from both staining procedures were cut with a
diamond knife (45°; Diatome), mounted on copper grids (200 mesh) and con-
trasted with conventional uranyl acetate (30 min) and Reynold’s lead citrate (5 min)
solutions. Sections were visualised using a Jeol 1400 transmission electron micro-
scope equipped with an Ultrascan ES1000 CCD camera (Gatan).
Lipid extraction and analysis
An ultra-performance liquid chromatography-mass/time-of-ﬂight mass spec-
trometry (UPLC/TOF-MS) platform was used for proﬁling chloroform/methanol lipid
extracts, providing coverage of glycerolipids, cholesteryl esters, sphingolipids and
glycerophospholipids (Barr et al., 2012). Different treatments and SE samples were
homogenised in the Precellys 24 homogeniser (Bertin Technologies) by mixing with
chloroform/methanol (2:1, V/V) and sodium chloride (50 mM) (overall ratio 1:30:3,
W/V/V), followed by protein precipitation. After brief vortexing, samples were in-
cubated at −20 °C for 1 h. After centrifugation at 16,000 g for 15min, the lower organic
phase was collected and the solvent removed. The dried extracts were then resus-
pended in acetronitrile/isopropanol (1:1), centrifuged at 16,000 g for 5 min and
supernatants were transferred to vials for UPLC-MS analysis on an Acquity-Xevo G2
Qtof mass spectrometry system (Waters Corporation). All UPLC analyses were per-
formed in duplicate.
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Metabolite identiﬁcation
Diacylglycerols (DAG), triacylglycerols (TAG), cholesteryl esters (ChoE),
glycerophosphatidylethanolamines (PE), glycerophosphatidylcholines (PC),
glycerophosphatidylinositols (PI), sphingomyelin (SM) and monohexosylceramides
(CMH) were identiﬁed as described previously by Barr et al. (2012). The characteri-
sation of the CER species (CER[ADS], CER[AH], CER[AP], CER[AS], CER[EOP], CER[EOS],
CER[NDS], CER[NH], CER[NP] and CER[NS]) was carried out as described in detail
by t’Kindt et al. (2012).
Data processing and statistical analysis
Data obtained with the UPLC-MS were processed with the TargetLynx applica-
tionmanager forMassLynx 4.1 (Waters Corporation), as described by Barr et al. (2012).
Intra-batch and inter-batch normalisation followed the procedure detailed by van
der Kloet et al. (2009). Univariate statistical analyses were performed to calculate
group percentage changes and Student’s t test, or Welch’s t test where unequal vari-
ances were found, was applied to evaluate the effect of the treatments by comparing
each treatment to the control. Statistical signiﬁcance was set at P < 0.05. All calcu-
lations were performed with R v3.1.1 (R Development Core Team).
Results
Lipid proﬁle of sphingolipid extracts
The lipid composition in the different treatment groups was
analysed by UPLC-MS.Metabolite data analysis showed different lipid
proﬁles for each treatment (Table 1). SPE-1 demonstrated the great-
est sphingomyelin concentration and the least amount of CER,
whereas SPE-2 showed relatively high levels of sphingomyelins, al-
though to a lesser degree than SPE-1, and the greatest CER
concentration. The greatest proportion of glycerolipids and
glycerophospholipids was found in SPE-3.
Histology and ultrastructural analysis
SEs were produced successfully after 14 days culture at the
air–liquid interface. On histological examination, differentiation
and maturation of the dermal and epidermal compartments,
as well as the dermo-epidermal junction, were observed in
control and treated SEs (Fig. 1). Dermal ﬁbroblasts were
present in the matrix of collagen ﬁbres and keratinocytes had
differentiated into a stratiﬁed squamous keratinised epithelium
(Fig. 1).
Ultrastructural analysis of the SC was performed by transmis-
sion electron microscopy after 14 days culture at the air–liquid
interface. In both control and treated SEs, there was a thick,
compact SC composed of different layers of corneocytes embed-
ded in an intercellular lipid-enriched matrix (Fig. 2). Numerous
lamellar bodies were observed at the border between the stratum
granulosum and SC in SPE-1 treated samples and the intercellular
spaces were ﬁlled with larger amounts of lipid material in some
areas of the SC (Fig. 2). Ruthenium tetroxide staining of inter-
corneocyte spaces indicated the presence of intercellular lamellae
that were well-organised in compact sheets. No other structural
differences were observed when comparing control and treated
samples (Fig. 3).
Fig. 1. Histological sections of (a) control and (b) sphingolipid extract (SPE)-1 treated canine skin equivalents. Haematoxylin and eosin stain.
Table 1
Lipid composition of sphingolipid extracts; data are shown as percent contribution.
Lipid class Treatments
SPE-1 SPE-2 SPE-3
Ceramides 0.81 26.70 11.63
Monohexosylceramides 0.32 0.04 0.06
Sphingomyelins 63.01 52.50 15.90
Monoacyl glycerols 0.06 0.04 0
Diacyl glycerols 4.16 10.67 0.91
Triacyl glycerols 1.41 18.98 36.22
Diacyl glycerophosphocholine 17.98 0.05 28.61
Monoether monoacyl phosphatidylcholine 1.74 0 6.61
Diacyl glycerophosphoethanolamine 0.60 0 0.05
Diacyl glycerophosphoinositol 0.06 0.02 0.01
Monoacyl glycerophosphocholine 9.85 0 0
Fig. 2. Electron micrographs of the stratum corneum in (a) control and (b, c and d)
sphingolipid extract (SPE)-1 treated canine skin equivalents. Samples were post-
ﬁxed with 1% osmium tetroxide and visualised by transmission electron microscopy.
Numerous lamellar bodies can be observed at the stratum granulosum and stratum
corneum border of SPE-1 treated samples (white arrows).
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Lipid proﬁles in canine skin equivalents exposed to sphingolipid
extracts
To determine whether the lipid proﬁle was modiﬁed in treated
SEs when compared to controls, 307 skin lipid metabolites belong-
ing to the glycerolipid group (DAG and TAG), sterol lipids (ChoE),
glycerophospholipids (PE, PC and PI) and sphingolipids (CER, SM and
CMH) were analysed by UPLC-MS. The relative concentration was
calculated for each treatment group and compared with those from
control tissues. The resulting data were arranged in a heat map, ac-
cording to the carbon number and unsaturation degree of the
esteriﬁed chains (Fig. 4).
In SPE-1 treated samples, there were signiﬁcant increases in 44/
99 (44.4%) CERmetabolites when compared with controls; increased
metabolites to CER[NS], CER[NDS], CER[NP], CER[AS], CER[AP], and
CER[EOS] subclasses. There were no signiﬁcant differences in CER
metabolites in SPE-2 and SPE-3 treated samples compared with con-
trols. There were no signiﬁcant differences among groups in
metabolites of glycerolipids, sterol lipids, glycerophospholipids or
other sphingolipids.
Relative concentrations of total CERs and different CER sub-
classes are shown in Fig. 5. Total CER increased signiﬁcantly after
both SPE-1 and SPE-2 supplementation (2.2-fold and 2.1-fold, re-
spectively). Likewise, CER[AP] and CER[EOS] subclasses also increased
signiﬁcantly after both SPE-1 (3.0-fold and 3.6-fold, respectively)
and SPE-2 (2.2-fold and 3.0-fold, respectively) treatment, whereas
CER[NS], CER[NDS], CER[NP], CER[AS] and CER[EOP] only in-
creased after SPE-1 supplementation (2.2-fold, 2.2-fold, 2.1-fold, 2.4-
fold and 1.9-fold, respectively). However, reductions in CER[NDS],
CER[ADS], CER[AP] and CER[EOS] were observed in SPE-3
treatment samples (1.6-fold, 3.5-fold, 3.7-fold and 6-fold,
respectively).
Discussion
In this study, a canine SE model was used to assess the effects
of different sphingolipid extracts on lipid composition. There were
signiﬁcant increases in total CERs and CER[NS], CER[NDS], CER[NP],
CER[AS], CER[AP], CER[EOS] and CER[EOP] subclasses after 2 weeks
of SPE-1 treatment, while SPE-2 induced a signiﬁcant increase in
total CERs, CER[AP] and CER[EOS]. In contrast, a reduction in these
CER subclasses has been demonstrated consistently in the SC in dogs
with AD. Reiter et al. (2009) reported lower proportions of CER[EOS]
and CER[EOP], whereas Yoon et al. (2011) found that total CERs,
CER[EOS], CER[EOP], CER[NP] and mixtures of CER[NDS/NS] and
CER[AS/NH] subclasses, were signiﬁcantly lower in atopic dogs than
unaffected dogs. In atopic dogs, Popa et al. (2011) reported reduc-
tions in protein-bound CER[OS] and CER[OP], which are degradation
products of free extractable CER[EOS] and CER[EOP], respectively.
Stahl et al. (2012) reported a decrease in total CER and CER[AH],
CER[AP], CER[AS], CER[NP], CER[EOP], CER[NS] and CER[EOS] frac-
tions in atopic Maltese-Beagle dogs after intradermal allergen
challenge.
Similar alterations in CER composition have also been detected
in other canine skin diseases. Yoon et al. (2013) indicated that quan-
tities of some CER subclasses, including CER[EOS], CER[EOP], CER[OH]
and a mixture of CER[AS/NH] were signiﬁcantly lower in Shih Tzu
dogs with seborrhoea than dogs without seborrhoea. A reduction
in total CERs, and CER[NP], CER[EOS] and CER[EOP] subclasses, has
also been reported in human AD (Di Nardo et al., 1998). Thus, the
CER subclasses most widely reported to be reduced in canine and
human AD, particularly CER[EOS] and CER[EOP], were increased after
SPE-1 treatment.
Interestingly, CER[EOS] and CER[EOP], the esteriﬁed
ω-hydroxyceramides with the largest carbon chains, are believed
to be critical for normal SC barrier function and are important car-
riers of linoleic acid, which is also involved in the maintenance of
the cutaneous water permeability barrier (Watson, 1998; Mizutani
et al., 2009). On the basis of these ﬁndings, CER[EOS] and CER[EOP]
are likely to represent the most relevant CER subclasses involved
in the pathogenesis of skin barrier defects in AD, although other CER
subclasses, such as short carbon chains CERs (CER[AP] and CER[NP]),
may also play a role.
These changes in total CER and CER subclasses observed in skin
samples after SPE-1 and SPE-2 treatment could be the result of direct
CER incorporation from sphingolipid extracts. However, SPE-3 con-
tained a greater proportion of CERs than SPE-1 and SEs treated with
SPE-3 did not show a signiﬁcant increase in total CERs or any CER
subclass, unlike SPE-1 and SPE-2. Therefore, such treatments may
be largely due to increased endogenous production, rather than the
presence of CERs in the treatment per se. Furthermore, the rela-
tively high content of sphingomyelins in SPE-1 and SPE-2, when
compared with SPE-3, could be responsible for stimulating syn-
thesis of CERs, since sphingomyelins are precursors of CER
biosynthesis in the skin (Feingold, 2007).
Ultrastructural abnormalities have been reported in the SC of dogs
affected with canine AD. Disorganisation of the lipid lamellae and
a wider and emptier intercellular space between corneocytes have
been reported in the SC of atopic dogs and horses (Inman et al., 2001;
Piekutowska et al., 2008; Jung et al., 2013; Marsella et al., 2014).
Marsella et al. (2010), using an experimental model for canine AD,
also observed disorganisation of the extracellular lipid lamellae,
Fig. 3. Electron micrographs of lipid lamellae in (a) control samples and (b) sphingolipid extract (SPE)-1 treated canine skin equivalents. Normal lipid lamellae structures
in alternating broad-narrow-broad lucent bands were observed in both control and treated samples. Samples were post-ﬁxed with 0.2% ruthenium tetroxide.
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increased width between corneocytes, lamellar bodies within
corneocytes and large amounts of amorphous intercellular lipids.
Jung et al. (2013) demonstrated improvement in AD-affected dogs
after topical treatment with preparations containing CERs, free fatty
acids and cholesterol, demonstrating their eﬃcacy in improving SC
structure and also helping to reduce TEWL, pruritus and Canine
Atopic Dermatitis Extent and Severity Index (CADESI) scores. More-
over, other studies of canine AD have reported an improvement in
SC organisation and lipid content after dietary supplementation with
ω-6/ω-3 fatty acids and topical sphingolipid-containing emulsion
therapy (Popa et al., 2011).
The present study showed numerous SC lipid lamellar-related
structures after SPE-1 treatment (intercorneocyte lipid fulﬁlment
and lamellar bodies). Since the permeability and microbial barri-
ers are maintained by lipids and proteins delivered to the
extracellular spaces of the SC through the secretion of lamellar
bodies (Feingold, 2012), an increase in the number of these
structures in the SE model after treatment with SPE-1 might
constitute a potential improvement in barrier function of the skin
in dogs. Moreover, the electron micrographs revealed a clear
trilaminar structure of lipid lamellae in altering broad-narrow-
broad lucent bands. CER[EOS] is considered to play an important
role in the formation and stabilisation of the trilaminar lipid
structure, resulting in this characteristic pattern (Madison et al.,
1987; Kuempel et al., 1998; Groen et al., 2010). Interestingly,
CER[EOS] showed the greatest increase of all CER subclasses after
SPE-1 treatment (3.6-fold), although this trilaminar structure was
present in both the control and treated samples. Taking into
account that the tissue model used in the present study was a
‘healthy’ SE model, one could speculate that the beneﬁcial effects
of this lipid-based treatment may be more evident in the SC of
atopic patients deﬁcient in CER[EOS].
Sphingolipids can be obtained from animal or plant sources and
may also be produced from genetically modiﬁed microorganisms.
Different commercial products containing sphingolipids are avail-
able, but most are plant-based. In mammals, most endogenous
sphingolipids contain sphingosine, which is not present in plants.
This compound is combined with fatty acid to form CERs. The
most common sphingolipids in humans (sphingomyelin and
galactosylceramides) are not present in plants (Sperling and Heinz,
2003). The sphingolipid extracts used in the present study were of
animal origin and therefore they presented a lipid proﬁle that was
more suitable for endogenous synthesis of CERs.
The SE model recapitulates the cellular and structural proper-
ties of skin and is an alternative to the use of animals in research.
The methodology described in the present study allows a canine
SE model to be generated from cells readily available from small
skin biopsies. The results obtained demonstrate that this tech-
nique is useful as a model to investigate the potential effects of lipid-
based formulations on canine skin.
Conclusions
The ﬁndings of this study indicate that sphingolipid-based treat-
ments may have a beneﬁcial effect for improving the skin barrier.
SPE-1 enhances endogenous production of CERs, contributing to the
formation of a well-organised SC. This treatment has potential for
use in skin diseases such as AD and seborrhoea, although clinical
studies are needed to conﬁrm these results and improve our un-
derstanding of the mechanisms involved.
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